Načítá se...

Comparative trial of sulphasalazine and oral sodium cromoglycate in the maintenance of remission in ulcerative colitis.

Patients with ulcerative colitis in remission were randomly allocated to treatment with sulphasalazine (2 g/day) or oral sodium cromoglycate (160 mg/day or 2 g/day), and the relapse rates in these treatment groups were compared during continued treatment for one year. The percentage cumulative relap...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Dronfield, M W, Langman, M J
Médium: Artigo
Jazyk:Inglês
Vydáno: 1978
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1412316/
https://ncbi.nlm.nih.gov/pubmed/33875
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!